Cai, N., Cheng, K., Ma, Y., Liu, S., Tao, R., Li, Y., . . . Zhang, W. (2024). Targeting MMP9 in CTNNB1 mutant hepatocellular carcinoma restores CD8+ T cell-mediated antitumour immunity and improves anti-PD-1 efficacy. Gut, 73(6), 985-999. https://doi.org/10.1136/gutjnl-2023-331342
Citace podle Chicago (17th ed.)Cai, Ning, et al. "Targeting MMP9 in CTNNB1 Mutant Hepatocellular Carcinoma Restores CD8+ T Cell-mediated Antitumour Immunity and Improves Anti-PD-1 Efficacy." Gut 73, no. 6 (2024): 985-999. https://doi.org/10.1136/gutjnl-2023-331342.
Citace podle MLA (9th ed.)Cai, Ning, et al. "Targeting MMP9 in CTNNB1 Mutant Hepatocellular Carcinoma Restores CD8+ T Cell-mediated Antitumour Immunity and Improves Anti-PD-1 Efficacy." Gut, vol. 73, no. 6, 2024, pp. 985-999, https://doi.org/10.1136/gutjnl-2023-331342.